Human Leukocyte Antigen Class I, MHC Class I Chain-Related Molecule A, and CD8+/Regulatory T-Cell Ratio: Which Variable Determines Survival of Cervical Cancer Patients?
暂无分享,去创建一个
S. H. van der Burg | E. Jordanova | G. Fleuren | G. Kenter | F. Prins | A. Gorter | L. Durrant | O. Ayachi | Ekaterina Jordanova
[1] E. Jordanova,et al. Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma , 2007, Cancer Immunology, Immunotherapy.
[2] D. Focosi,et al. CD57 expression on lymphoma microenvironment as a new prognostic marker related to immune dysfunction. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] G. Rabinovich,et al. Immunosuppressive strategies that are mediated by tumor cells. , 2007, Annual review of immunology.
[4] F. Garrido,et al. MHC class I antigens and immune surveillance in transformed cells. , 2007, International review of cytology.
[5] C. Woodman,et al. The natural history of cervical HPV infection: unresolved issues , 2007, Nature Reviews Cancer.
[6] Ekaterina S Jordanova,et al. High number of intraepithelial CD8+ tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer. , 2007, Cancer research.
[7] F. Bray,et al. Chapter 2: The burden of HPV-related cancers. , 2006, Vaccine.
[8] R. Offringa,et al. Selective cytotoxic T-lymphocyte targeting of tumor immune escape variants , 2006, Nature Medicine.
[9] I. Ellis,et al. Expression of the stress‐related MHC class I chain‐related protein MICA is an indicator of good prognosis in colorectal cancer patients , 2006, International journal of cancer.
[10] yang-xin fu,et al. Tumor-infiltrating T lymphocytes: friends or foes? , 2006, Laboratory Investigation.
[11] T. Oshikiri,et al. Concurrent infiltration by CD8+ T cells and CD4+ T cells is a favourable prognostic factor in non-small-cell lung carcinoma , 2006, British Journal of Cancer.
[12] Gerd Ritter,et al. Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[13] D. Chan,et al. Risk association between human leukocyte antigen-A allele and high-risk human papillomavirus infection for cervical neoplasia in Chinese women. , 2005, The Journal of infectious diseases.
[14] M. Schiff,et al. HLA alleles and risk of cervical intraepithelial neoplasia among southwestern American Indian women. , 2005, Human immunology.
[15] E. S. Tiersma,et al. Psychosocial factors and the course of cervical intra-epithelial neoplasia: a prospective study. , 2005, Gynecologic oncology.
[16] Cornelis J H van de Velde,et al. Four‐color staining combining fluorescence and brightfield microscopy for simultaneous immune cell phenotyping and localization in tumor tissue sections , 2005, Microscopy research and technique.
[17] R. Tollenaar,et al. Natural killer cells infiltrating colorectal cancer and MHC class I expression. , 2005, Molecular immunology.
[18] R. Leiden. Psychosocial factors and the course of cervical intraepithelial neoplasia: A prospective study , 2005 .
[19] D. Doherty,et al. Characterization of NKR+ T-cell subsets in human bone marrow: implications for immunosurveillance of neoplasia. , 2005, Clinical immunology.
[20] G. Fleuren,et al. Prognostic relevance of TGF‐β1 and PAI‐1 in cervical cancer , 2004 .
[21] L. Staudt,et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. , 2004, The New England journal of medicine.
[22] George Coukos,et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival , 2004, Nature Medicine.
[23] R. Fisker,et al. Leukocyte orchestration in blood and tumour tissue following interleukin-2 based immunotherapy in metastatic renal cell carcinoma , 2004, Cancer Immunology, Immunotherapy.
[24] H. Putter,et al. Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysis , 2004, Laboratory Investigation.
[25] E. S. Tiersma,et al. Psychosocial factors and the grade of cervical intra-epithelial neoplasia: a semi-prospective study. , 2004, Gynecologic oncology.
[26] D. Raulet. Roles of the NKG2D immunoreceptor and its ligands , 2003, Nature Reviews Immunology.
[27] S. Bellone,et al. Induction of tumor-specific cytotoxicity in tumor infiltrating lymphocytes by HPV16 and HPV18 E7-pulsed autologous dendritic cells in patients with cancer of the uterine cervix. , 2003, Gynecologic oncology.
[28] J. Hjelmborg,et al. Prognostic value of the CD4+/CD8+ ratio of tumour infiltrating lymphocytes in colorectal cancer and HLA-DR expression on tumour cells , 2003, Cancer Immunology, Immunotherapy.
[29] George Coukos,et al. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. , 2003, The New England journal of medicine.
[30] D. Characiejus,et al. Predictive value of CD8highCD57+ lymphocyte subset in interferon therapy of patients with renal cell carcinoma. , 2002, Anticancer research.
[31] Noam Brown,et al. The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapies , 2002, The Journal of pathology.
[32] H. Pilch,et al. Human Papillomavirus Type 33 E7 Peptides Presented by HLA-DR*0402 to Tumor-Infiltrating T Cells in Cervical Cancer , 2000, Journal of Virology.
[33] A. Zwinderman,et al. Surgically-treated early cervical cancer: Prognostic factors and the significance of depth of tumor invasion. , 1999, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.
[34] H. Chao,et al. Lymphocyte-infiltrated FIGO Stage IIB squamous cell carcinoma of the cervix is a prominent factor for disease-free survival. , 1999, European journal of gynaecological oncology.
[35] B. Nielsen,et al. Quality control of immunohistochemical evaluation of tumour-associated plasminogen activators and related components. European BIOMED-1 Concerted Action on Clinical Relevance of Proteases in Tumour Invasion and Metastasis. , 1998, European journal of cancer.
[36] L. Borysiewicz,et al. Infiltration of cervical cancer tissue with human papillomavirus-specific cytotoxic T-lymphocytes. , 1997, Cancer research.
[37] C. Meijer,et al. Assessment of cytotoxic T-lymphocyte phenotype using the specific markers granzyme B and TIA-1 in cervical neoplastic lesions. , 1997, British Journal of Cancer.
[38] G. Fleuren,et al. Association of allele-specific HLA expression and histopathologic progression of cervical carcinoma. , 1996, Gynecologic oncology.
[39] B. Delahunt,et al. Infiltration By Immunocompetent Cells In Early Stage Invasive Carcinoma Of The Uterine Cervix: A prognostic study , 1996, Pathology.
[40] G. Fleuren,et al. Altered HLA expression by metastatic cervical carcinoma cells as a factor in impaired immune surveillance. , 1995, Gynecologic oncology.
[41] G. Fleuren,et al. Isolation and characterization of tumor‐infiltrating lymphocytes from cervical carcinoma , 1994, International journal of cancer.
[42] G. Fleuren,et al. The expression of histocompatibility-related leukocyte antigens in the pathway to cervical carcinoma. , 1994, American journal of clinical pathology.
[43] G. Fleuren,et al. Association between HLA-expression and infiltration of immune cells in cervical carcinoma. , 1993, Laboratory investigation; a journal of technical methods and pathology.
[44] J. Bodmer,et al. Immunological paradox in testicular tumours: the presence of a large number of activated T-cells despite the complete absence of MHC antigens. , 1993, European journal of cancer.
[45] M. Palmer,et al. Human trophoblast and the choriocarcinoma cell line BeWo express a truncated HLA Class I molecule. , 1990, Journal of immunology.